Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Toi

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
International Journal of Oncology|April 30, 2011
Biological and clinical significance of hepatocyte growth factor in breast cancerT Narita, N Kimura, C Mitsuoka, et al.
Surgery Today|January 1, 1993
Primary squamous cell carcinoma of the breast after cured Hodgkin's diseaseK Kuroi, A Osaki, H Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients]T Saeki, K Jinushi, R Kim, et al.
Biochemical and Biophysical Research Communications|February 17, 2001
MDM2 enhances the function of estrogen receptor alpha in human breast cancer cellsS Saji, N Okumura, H Eguchi, et al.
International Journal of Oncology|June 6, 1998
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patientsG Gasparini, M Toi, P Verderio, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 10, 2005
Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case reportN Kuroda, T Hamauzu, M Toi, et al.
British Journal of Cancer|October 29, 2011
Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancerM Kanai, H Ishiguro, Y Mori, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|October 1, 1989
[Expression of the epidermal growth factor receptor in esophageal cancer]H Mukaida, T Hirai, M Toi, et al.
Histology and Histopathology|December 4, 2004
The participation of myofibroblasts in the capsular formation of human conventional and chromophobe renal cell carcinomasN Shimasaki, N Kuroda, L Guo, et al.
Angiogenesis|January 1, 1997
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implicationsM Toi, M Gion, E Biganzoli, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
International Journal of Oncology|April 30, 2011
Biological and clinical significance of hepatocyte growth factor in breast cancerT Narita, N Kimura, C Mitsuoka, et al.
Surgery Today|January 1, 1993
Primary squamous cell carcinoma of the breast after cured Hodgkin's diseaseK Kuroi, A Osaki, H Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients]T Saeki, K Jinushi, R Kim, et al.
Biochemical and Biophysical Research Communications|February 17, 2001
MDM2 enhances the function of estrogen receptor alpha in human breast cancer cellsS Saji, N Okumura, H Eguchi, et al.
International Journal of Oncology|June 6, 1998
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patientsG Gasparini, M Toi, P Verderio, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 10, 2005
Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case reportN Kuroda, T Hamauzu, M Toi, et al.
British Journal of Cancer|October 29, 2011
Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancerM Kanai, H Ishiguro, Y Mori, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|October 1, 1989
[Expression of the epidermal growth factor receptor in esophageal cancer]H Mukaida, T Hirai, M Toi, et al.
Histology and Histopathology|December 4, 2004
The participation of myofibroblasts in the capsular formation of human conventional and chromophobe renal cell carcinomasN Shimasaki, N Kuroda, L Guo, et al.
Angiogenesis|January 1, 1997
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implicationsM Toi, M Gion, E Biganzoli, et al.
Pageof 20